# Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients

> **NCT04842825** · PHASE3 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** Er Zhi Wan combined with Si Wu Tang
- **DRUG:** Recombinant Human Follitropin Alfa 、Fructose 、Tetyacycline Hydrochloride Capsules、Cetrorelix Acetate Powder

## Key facts

- **NCT ID:** NCT04842825
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842825, "Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04842825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*